News
Every dated milestone across Agronomics and its portfolio, newest first.
-
Laverock Therapeutics · In-vivo programmes in oncology and genetic medicine
In-vivo CAR-T for solid tumours, and in-vivo gene silencing aimed first at nervous-system and metabolic disorders.
-
Laverock Therapeutics · In-vivo data support solid-tumour programmes
-
Laverock Therapeutics · Collaboration with ReNeuron
Pairs Laverock's gene-silencing platform with ReNeuron's exosome delivery to test in-vivo gene targeting. Terms not disclosed.